How Following Medical Artificial Intelligence Advice Can Mitigate Malpractice Liability: Cross-National Insights from a Randomized Trial [0.03%]
遵循医疗人工智能建议可减轻过失责任：随机对照试验的跨国见解
Alessandro Tacconelli,Jakob Merane,Aileen Nielsen et al.
Alessandro Tacconelli et al.
Artificial intelligence (AI) increasingly influences clinical decision-making, yet its recommendations may diverge from standard care. Although malpractice concerns are thought to discourage physicians from following AI advice, experimental...
Role of 18F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy [0.03%]
前列腺切除术后复发性前列腺癌的18F-PSMA PET/MRI作用
Alexandra Paule,Soizic Masson,Johan Rose Dite Modestine et al.
Alexandra Paule et al.
18F-PSMA PET/CT and pelvic MRI are useful for assessing biochemical recurrence of prostate cancer after prostatectomy. We evaluated the role of 18F-PSMA PET/MRI in a 1-stop-shop protocol combining a single injection of 18F-PSMA, followed by...
[177Lu]Lu-DOTATATE for Advanced Intracranial Meningioma: The MOMENTUM-1 (RTOG3523) Study Investigators' Perspective [0.03%]
[177Lu]Lu-DOTA-TATE治疗复发高级别脑膜瘤：MOMENTUM-1(RTOG3523)研究者述评
Sylvia C Kurz,Erik P Sulman
Sylvia C Kurz
From Uptake Restoration to Clinical Actionability: Toward Dosimetry-Defined Short-Course Redifferentiation in RAIR Thyroid Cancer [0.03%]
从恢复摄取到临床可操作性：向剂量定义的短程再分化治疗RAIR甲状腺癌前进
Chanchan Shan,Shichen Xu,Jian Zhang
Chanchan Shan
Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing 68Ga-PSMA PET/CT [0.03%]
常规68Ga-PSMA PET/CT显像基础上额外增加盆腔延迟显像对前列腺癌生化复发患者诊断价值几何？
Karen Y Jia,Jonathan Kuten,Heather Y Jia et al.
Karen Y Jia et al.
The detection of biochemical recurrence (BCR) of prostate cancer remains challenging, as small-volume disease may fall below the sensitivity of standard imaging. Prostate-specific membrane antigen (PSMA) PET/CT is currently the most sensiti...
Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool [0.03%]
胶质母细胞瘤的转化诊疗学：FAPI-46作为精准医学工具
Pauline Jeanjean,Abir Swaidan,Christopher Tse et al.
Pauline Jeanjean et al.
Glioblastoma represents the most lethal form of brain cancer, characterized by a 5-y survival rate of approximately 4%. Fibroblast activation protein (FAP), expressed within both the tumor microenvironment and glioblastoma cells, has been i...
Dosimetry Results from the Phase 1b/3 ACTION-1 Trial of [225Ac]Ac-DOTATATE (RYZ101) in Patients with Somatostatin Receptor-Expressing, Well-Differentiated GEP-NETs [0.03%]
用于治疗表达生长抑素受体的胃肠胰神经内分泌肿瘤的[225Ac]Ac-DOTATATE（RYZ101）一期b/三期ACTION-1临床试验剂量学结果
George Sgouros,Gary A Ulaner,Bin He et al.
George Sgouros et al.
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are biologically and clinically heterogeneous tumors, most of which overexpress somatostatin receptors (SSTRs). The presence of SSTRs enables staging and allows patient selection for t...
Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis [0.03%]
FAPI-PET/MRI评估子宫内膜异位症范围的初步结果
Philipp Schindler,Jonas Brandt,Stefanie Bobe et al.
Philipp Schindler et al.
Endometriosis is a common gynecologic disorder often associated with chronic pelvic pain, infertility, and reduced quality of life. Conventional imaging modalities, such as transvaginal ultrasound and MRI, may underestimate the extent of di...
Sub-0.5-mm Resolution PET Versus Autoradiography: Comparison of mGluR1 Concentrations in Mouse Brain [0.03%]
sub-0.5毫米分辨率PET与自放射分析法比较鼠脑mGluR1浓度的分布
Han Gyu Kang,Hideaki Tashima,Hidekatsu Wakizaka et al.
Han Gyu Kang et al.
For mouse brain PET imaging with high quantification accuracy, ultrahigh resolution is essential. Metabotropic glutamate receptors are important molecular targets, linked to various neurologic diseases. Here, we report the comparison of in ...